Health News Today roundup for November 10, 2026 covering FDA GLP-1 vision warning, Listeria sandwich recall, and sleep apnea trial

Health News Today, Nov 10: GLP-1 Warning, Recall, Apnea

Mr Steady Natural Health

1 hour ago

4 min read

In health news today, federal regulators ordered a class-wide eye-safety warning on popular diabetes and weight medications while posting a Listeria recall on grab-and-go breakfast sandwiches. Late-breaking American Heart Association trial data also highlighted a daily pill for sleep apnea alongside growing momentum to report hidden heart clues on routine mammograms. Meanwhile, a new investigation shows how early Medicaid work-rule checks are disrupting care for seriously ill adults nearing Medicare age.

Today's 5 headlines chart for November 10, 2026 comparing US health news updates and practical steps for adults over 45

FDA Orders Vision-Loss Warning on All GLP-1 Medications

The U.S. Food and Drug Administration announced November 9 that drugmakers must add a safety warning across all glucagon-like peptide-1 receptor agonist (GLP-1) medications over a rare optic nerve condition, according to an FDA Drug Safety Communication covered by NBC News and CNN Health. The requirement spans major brands including Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Trulicity, and Foundayo. Regulators cited a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), caused by reduced blood flow to the front of the optic nerve, which can trigger sudden, painless vision loss in one eye—often noticed upon waking—with no known treatment. Across 126 randomized trials reviewed by the agency, NAION occurred at 6.4 cases per 100,000 person-years among GLP-1 users versus 3.8 cases in comparison groups.

What it means for you: Do not stop a prescribed diabetes or weight medication on your own, since sudden discontinuation can disrupt blood sugar or heart care. Contact your doctor or eye specialist immediately if you notice sudden blurriness, blind spots, faded colors, or vision loss in one eye.

FDA Posts Listeria Recall on Ready-to-Eat Biscuit Sandwiches

Fresh & Ready Foods LLC of Renton, Washington recalled 2,414 units of its 4.6-ounce Fresh To You Sausage, Egg & Cheese Biscuit Sandwiches over potential Listeria monocytogenes contamination, according to an FDA recall alert posted November 8 and updated November 9. Packaged in clear film under SKU 3100048 and UPC 8 405493 0168 4, the sandwiches carry front-label "Fresh Thru" dates from 11/07 through 11/19. They were distributed between October 25 and November 4 to workplace break rooms, cafeterias, and refrigerated vending machines across Washington and Oregon. Regulators linked the action to an upstream biscuit recall by supplier C.H. Guenther & Son, noting no other Fresh & Ready items are affected. While healthy people may have brief symptoms, Listeria can cause severe bloodstream or nervous system infections in older adults.

What it means for you: Check home or workplace refrigerators for Fresh To You biscuit sandwiches dated 11/07 through 11/19 and throw them away or request a refund. If you ate a recalled sandwich and develop fever, stiff neck, muscle aches, or digestive upset, call your healthcare provider promptly.

Daily Pill Foundayo Eases Sleep Apnea in Late-Stage Trials

Eli Lilly's once-daily oral GLP-1 pill Foundayo (orforglipron) significantly reduced nighttime breathing disruptions in two year-long Phase 3 trials, STAT News reported November 9 from data presented at the American Heart Association meeting and published in JAMA. Among adults with moderate-to-severe obstructive sleep apnea not using positive airway pressure (PAP) machines, Foundayo cut scores on the apnea-hypopnea index by 17.8 breathing events per hour over 52 weeks, compared with 4.5 fewer events per hour on placebo. About 28% of treated participants reached remission or mild sleep apnea, more than double the 13% placebo rate. Still, researchers noted that the daily pill appeared somewhat less potent than Lilly's injectable drug Zepbound, which already holds federal clearance for sleep apnea alongside excess weight.

What it means for you: Untreated sleep apnea strains the heart and blood vessels after 45, yet many older adults struggle to wear CPAP masks every night. Continue using your prescribed sleep equipment for now, and ask your physician or sleep specialist which proven management options fit your health profile.

Early Medicaid Work Rules Disrupt Care for Older Patients

An investigation published November 9 by NPR and KFF Health News examines how the first state rollout of new federal Medicaid work requirements is creating coverage hurdles for seriously ill older adults ahead of a broader January 2027 mandate. Nebraska launched its program eight months early, requiring roughly 70,000 adult enrollees up to age 64—just shy of Medicare at 65—to verify 80 monthly hours of work or qualifying activities unless exempted. State officials say 93% of existing enrollees kept coverage and 86% of affected applicants met the rule or an exclusion with help from $8.2 million in contractor staffing. Yet local clinics and advocates report widespread confusion, citing cases like a 64-year-old Omaha man with COPD, diabetes, and newly diagnosed kidney cancer who lost coverage and canceled a CT scan.

What it means for you: If you or a family member aged 45 to 64 uses Medicaid before turning 65, open state renewal notices promptly as work-reporting rules expand across most states in early 2027. Ask your doctor, clinic social worker, or state Medicaid office early about medical-frailty exemption forms so needed care stays uninterrupted.

Routine Mammograms May Flag Hidden Heart Risk in Women

Routine breast cancer screenings could double as an early warning check for silent cardiovascular risk in women, Healthline News reported November 8. Standard X-ray mammograms can detect breast arterial calcification (BAC)—harmless calcium deposits inside tiny breast arteries that appear as thin, parallel white "tram-track" lines. While BAC does not signal breast cancer, clinical research links it to a 51% higher likelihood of heart disease or stroke, reflecting shared vascular stressors like high blood pressure, elevated cholesterol, and diabetes. Because heart disease causes one in three female deaths in the U.S. and often progresses without classic chest pain, cardiology and radiology leaders alongside Medicare officials are pushing for routine BAC reporting, following a new Maryland patient-notification law. Pairing screening awareness with everyday heart-healthy habits may help women address risks earlier.

What it means for you: Women aged 45 to 75 who already get regular mammograms may gain useful vascular clues from a screening already on their calendar. At your next checkup, ask your doctor whether breast arterial calcifications appeared on your mammogram and whether reviewing blood pressure or cholesterol makes sense.

Related reading: 2026 VisiFlora macular nutrition audit.

Sources

This roundup is for general information only and is not medical advice.